nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefdinir—SLC22A5—Dactinomycin—skin cancer	0.494	1	CbGbCtD
Cefdinir—Vaginal inflammation—Imiquimod—skin cancer	0.00513	0.0105	CcSEcCtD
Cefdinir—Vaginal infection—Imiquimod—skin cancer	0.00484	0.00994	CcSEcCtD
Cefdinir—Digestion impaired—Temozolomide—skin cancer	0.0046	0.00944	CcSEcCtD
Cefdinir—Coagulopathy—Dactinomycin—skin cancer	0.00437	0.00896	CcSEcCtD
Cefdinir—Interstitial lung disease—Temozolomide—skin cancer	0.00434	0.00892	CcSEcCtD
Cefdinir—Hepatic function abnormal—Imiquimod—skin cancer	0.00426	0.00875	CcSEcCtD
Cefdinir—Interstitial pneumonia—Docetaxel—skin cancer	0.00423	0.00869	CcSEcCtD
Cefdinir—Cholestasis—Temozolomide—skin cancer	0.00405	0.00831	CcSEcCtD
Cefdinir—Coagulopathy—Temozolomide—skin cancer	0.00395	0.00811	CcSEcCtD
Cefdinir—Dermatitis exfoliative—Imiquimod—skin cancer	0.00395	0.0081	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Vemurafenib—skin cancer	0.00393	0.00807	CcSEcCtD
Cefdinir—Purpura—Imiquimod—skin cancer	0.00386	0.00793	CcSEcCtD
Cefdinir—Cardiac failure—Imiquimod—skin cancer	0.00382	0.00783	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.00334	0.00685	CcSEcCtD
Cefdinir—Aplastic anaemia—Dactinomycin—skin cancer	0.00319	0.00655	CcSEcCtD
Cefdinir—Vaginal inflammation—Temozolomide—skin cancer	0.00307	0.00631	CcSEcCtD
Cefdinir—Dyspepsia—Vismodegib—skin cancer	0.00306	0.00628	CcSEcCtD
Cefdinir—Pancytopenia—Imiquimod—skin cancer	0.00306	0.00628	CcSEcCtD
Cefdinir—Decreased appetite—Vismodegib—skin cancer	0.00302	0.0062	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Vismodegib—skin cancer	0.003	0.00616	CcSEcCtD
Cefdinir—Constipation—Vismodegib—skin cancer	0.00297	0.0061	CcSEcCtD
Cefdinir—Candida infection—Temozolomide—skin cancer	0.00293	0.00603	CcSEcCtD
Cefdinir—MPO—endothelium—skin cancer	0.00292	0.152	CbGeAlD
Cefdinir—Vaginal infection—Temozolomide—skin cancer	0.0029	0.00596	CcSEcCtD
Cefdinir—Ileus—Docetaxel—skin cancer	0.00289	0.00593	CcSEcCtD
Cefdinir—Interstitial lung disease—Docetaxel—skin cancer	0.00289	0.00593	CcSEcCtD
Cefdinir—Aplastic anaemia—Temozolomide—skin cancer	0.00289	0.00593	CcSEcCtD
Cefdinir—Erythema multiforme—Vemurafenib—skin cancer	0.00286	0.00586	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.00284	0.00584	CcSEcCtD
Cefdinir—Gastrointestinal pain—Vismodegib—skin cancer	0.00284	0.00583	CcSEcCtD
Cefdinir—Acute coronary syndrome—Imiquimod—skin cancer	0.00283	0.00581	CcSEcCtD
Cefdinir—Myocardial infarction—Imiquimod—skin cancer	0.00281	0.00578	CcSEcCtD
Cefdinir—Conjunctivitis—Imiquimod—skin cancer	0.00279	0.00573	CcSEcCtD
Cefdinir—Abdominal pain—Vismodegib—skin cancer	0.00275	0.00564	CcSEcCtD
Cefdinir—Hepatic failure—Dactinomycin—skin cancer	0.00275	0.00564	CcSEcCtD
Cefdinir—MPO—blood vessel—skin cancer	0.00269	0.14	CbGeAlD
Cefdinir—Haemoglobin—Imiquimod—skin cancer	0.00259	0.00532	CcSEcCtD
Cefdinir—Haemorrhage—Imiquimod—skin cancer	0.00258	0.00529	CcSEcCtD
Cefdinir—Rash maculo-papular—Fluorouracil—skin cancer	0.00257	0.00529	CcSEcCtD
Cefdinir—Asthenia—Vismodegib—skin cancer	0.00249	0.00512	CcSEcCtD
Cefdinir—Hepatic failure—Temozolomide—skin cancer	0.00248	0.0051	CcSEcCtD
Cefdinir—Pruritus—Vismodegib—skin cancer	0.00246	0.00505	CcSEcCtD
Cefdinir—Erythema multiforme—Imiquimod—skin cancer	0.00244	0.005	CcSEcCtD
Cefdinir—Diarrhoea—Vismodegib—skin cancer	0.00238	0.00488	CcSEcCtD
Cefdinir—Dermatitis exfoliative—Temozolomide—skin cancer	0.00236	0.00486	CcSEcCtD
Cefdinir—Purpura—Temozolomide—skin cancer	0.00232	0.00475	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Dactinomycin—skin cancer	0.00222	0.00456	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Dactinomycin—skin cancer	0.00222	0.00456	CcSEcCtD
Cefdinir—Vomiting—Vismodegib—skin cancer	0.00221	0.00453	CcSEcCtD
Cefdinir—Rash—Vismodegib—skin cancer	0.00219	0.0045	CcSEcCtD
Cefdinir—Dermatitis—Vismodegib—skin cancer	0.00219	0.00449	CcSEcCtD
Cefdinir—Pancytopenia—Bleomycin—skin cancer	0.00217	0.00446	CcSEcCtD
Cefdinir—Anaphylactic shock—Vemurafenib—skin cancer	0.00215	0.00441	CcSEcCtD
Cefdinir—Cardiac failure—Fluorouracil—skin cancer	0.00211	0.00433	CcSEcCtD
Cefdinir—Nausea—Vismodegib—skin cancer	0.00206	0.00424	CcSEcCtD
Cefdinir—Agitation—Imiquimod—skin cancer	0.00206	0.00423	CcSEcCtD
Cefdinir—Pneumonia—Bleomycin—skin cancer	0.00205	0.00421	CcSEcCtD
Cefdinir—Pancytopenia—Dactinomycin—skin cancer	0.00202	0.00416	CcSEcCtD
Cefdinir—Acute coronary syndrome—Bleomycin—skin cancer	0.00201	0.00413	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.00201	0.00413	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Temozolomide—skin cancer	0.00201	0.00413	CcSEcCtD
Cefdinir—Myocardial infarction—Bleomycin—skin cancer	0.002	0.0041	CcSEcCtD
Cefdinir—Neutropenia—Dactinomycin—skin cancer	0.00199	0.00409	CcSEcCtD
Cefdinir—Stomatitis—Bleomycin—skin cancer	0.00199	0.00408	CcSEcCtD
Cefdinir—Loss of consciousness—Imiquimod—skin cancer	0.00197	0.00405	CcSEcCtD
Cefdinir—Candida infection—Docetaxel—skin cancer	0.00195	0.00401	CcSEcCtD
Cefdinir—Haematuria—Bleomycin—skin cancer	0.00194	0.00399	CcSEcCtD
Cefdinir—Convulsion—Imiquimod—skin cancer	0.00194	0.00399	CcSEcCtD
Cefdinir—Hypertension—Imiquimod—skin cancer	0.00194	0.00398	CcSEcCtD
Cefdinir—Pneumonia—Dactinomycin—skin cancer	0.00191	0.00393	CcSEcCtD
Cefdinir—Chest pain—Imiquimod—skin cancer	0.00191	0.00392	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.00188	0.00387	CcSEcCtD
Cefdinir—Dry mouth—Imiquimod—skin cancer	0.00187	0.00383	CcSEcCtD
Cefdinir—Decreased appetite—Vemurafenib—skin cancer	0.00187	0.00383	CcSEcCtD
Cefdinir—Stomatitis—Dactinomycin—skin cancer	0.00185	0.00381	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00185	0.0038	CcSEcCtD
Cefdinir—Haemoglobin—Bleomycin—skin cancer	0.00184	0.00378	CcSEcCtD
Cefdinir—Constipation—Vemurafenib—skin cancer	0.00184	0.00377	CcSEcCtD
Cefdinir—Pancytopenia—Temozolomide—skin cancer	0.00183	0.00376	CcSEcCtD
Cefdinir—Haemorrhage—Bleomycin—skin cancer	0.00183	0.00376	CcSEcCtD
Cefdinir—Neutropenia—Temozolomide—skin cancer	0.0018	0.0037	CcSEcCtD
Cefdinir—Shock—Imiquimod—skin cancer	0.0018	0.0037	CcSEcCtD
Cefdinir—Agranulocytosis—Dactinomycin—skin cancer	0.00177	0.00364	CcSEcCtD
Cefdinir—Anorexia—Imiquimod—skin cancer	0.00174	0.00358	CcSEcCtD
Cefdinir—Pneumonia—Temozolomide—skin cancer	0.00173	0.00355	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.0017	0.0035	CcSEcCtD
Cefdinir—Body temperature increased—Vemurafenib—skin cancer	0.0017	0.00348	CcSEcCtD
Cefdinir—Pancytopenia—Fluorouracil—skin cancer	0.00169	0.00347	CcSEcCtD
Cefdinir—Stomatitis—Temozolomide—skin cancer	0.00168	0.00344	CcSEcCtD
Cefdinir—Insomnia—Imiquimod—skin cancer	0.00166	0.0034	CcSEcCtD
Cefdinir—Hepatic failure—Docetaxel—skin cancer	0.00165	0.00339	CcSEcCtD
Cefdinir—Somnolence—Imiquimod—skin cancer	0.00163	0.00334	CcSEcCtD
Cefdinir—Erythema multiforme—Dactinomycin—skin cancer	0.00161	0.00331	CcSEcCtD
Cefdinir—Dyspepsia—Imiquimod—skin cancer	0.00161	0.00331	CcSEcCtD
Cefdinir—Pneumonia—Fluorouracil—skin cancer	0.00159	0.00327	CcSEcCtD
Cefdinir—Decreased appetite—Imiquimod—skin cancer	0.00159	0.00327	CcSEcCtD
Cefdinir—Hypersensitivity—Vemurafenib—skin cancer	0.00158	0.00325	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Imiquimod—skin cancer	0.00158	0.00324	CcSEcCtD
Cefdinir—Acute coronary syndrome—Fluorouracil—skin cancer	0.00156	0.00321	CcSEcCtD
Cefdinir—Renal impairment—Docetaxel—skin cancer	0.00156	0.0032	CcSEcCtD
Cefdinir—Myocardial infarction—Fluorouracil—skin cancer	0.00155	0.00319	CcSEcCtD
Cefdinir—Haemoglobin—Temozolomide—skin cancer	0.00155	0.00319	CcSEcCtD
Cefdinir—Stomatitis—Fluorouracil—skin cancer	0.00154	0.00317	CcSEcCtD
Cefdinir—Haemorrhage—Temozolomide—skin cancer	0.00154	0.00317	CcSEcCtD
Cefdinir—Conjunctivitis—Fluorouracil—skin cancer	0.00154	0.00316	CcSEcCtD
Cefdinir—Asthenia—Vemurafenib—skin cancer	0.00154	0.00316	CcSEcCtD
Cefdinir—Cardiac failure—Docetaxel—skin cancer	0.00152	0.00312	CcSEcCtD
Cefdinir—Pruritus—Vemurafenib—skin cancer	0.00152	0.00312	CcSEcCtD
Cefdinir—Gastrointestinal pain—Imiquimod—skin cancer	0.0015	0.00307	CcSEcCtD
Cefdinir—Agranulocytosis—Fluorouracil—skin cancer	0.00148	0.00304	CcSEcCtD
Cefdinir—Diarrhoea—Vemurafenib—skin cancer	0.00147	0.00301	CcSEcCtD
Cefdinir—Erythema multiforme—Temozolomide—skin cancer	0.00146	0.003	CcSEcCtD
Cefdinir—SLC15A1—epithelium—skin cancer	0.00146	0.076	CbGeAlD
Cefdinir—Abdominal pain—Imiquimod—skin cancer	0.00145	0.00297	CcSEcCtD
Cefdinir—Body temperature increased—Imiquimod—skin cancer	0.00145	0.00297	CcSEcCtD
Cefdinir—Haemoglobin—Fluorouracil—skin cancer	0.00143	0.00294	CcSEcCtD
Cefdinir—Leukopenia—Bleomycin—skin cancer	0.00143	0.00293	CcSEcCtD
Cefdinir—Haemorrhage—Fluorouracil—skin cancer	0.00142	0.00292	CcSEcCtD
Cefdinir—Dizziness—Vemurafenib—skin cancer	0.00142	0.00291	CcSEcCtD
Cefdinir—MPO—connective tissue—skin cancer	0.00138	0.072	CbGeAlD
Cefdinir—Vomiting—Vemurafenib—skin cancer	0.00136	0.0028	CcSEcCtD
Cefdinir—Chest pain—Bleomycin—skin cancer	0.00136	0.00278	CcSEcCtD
Cefdinir—Rash—Vemurafenib—skin cancer	0.00135	0.00278	CcSEcCtD
Cefdinir—Dermatitis—Vemurafenib—skin cancer	0.00135	0.00278	CcSEcCtD
Cefdinir—Hypersensitivity—Imiquimod—skin cancer	0.00135	0.00277	CcSEcCtD
Cefdinir—Headache—Vemurafenib—skin cancer	0.00134	0.00276	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.00134	0.00274	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.00134	0.00274	CcSEcCtD
Cefdinir—Leukopenia—Dactinomycin—skin cancer	0.00133	0.00273	CcSEcCtD
Cefdinir—Asthenia—Imiquimod—skin cancer	0.00131	0.0027	CcSEcCtD
Cefdinir—MPO—epithelium—skin cancer	0.00131	0.0684	CbGeAlD
Cefdinir—Anaphylactic shock—Bleomycin—skin cancer	0.0013	0.00267	CcSEcCtD
Cefdinir—Pruritus—Imiquimod—skin cancer	0.00129	0.00266	CcSEcCtD
Cefdinir—Nausea—Vemurafenib—skin cancer	0.00127	0.00262	CcSEcCtD
Cefdinir—Thrombocytopenia—Bleomycin—skin cancer	0.00127	0.00261	CcSEcCtD
Cefdinir—SLC15A1—mammalian vulva—skin cancer	0.00126	0.0659	CbGeAlD
Cefdinir—Diarrhoea—Imiquimod—skin cancer	0.00125	0.00257	CcSEcCtD
Cefdinir—MPO—skin of body—skin cancer	0.00125	0.065	CbGeAlD
Cefdinir—Anorexia—Bleomycin—skin cancer	0.00124	0.00254	CcSEcCtD
Cefdinir—Agitation—Temozolomide—skin cancer	0.00123	0.00254	CcSEcCtD
Cefdinir—Pancytopenia—Docetaxel—skin cancer	0.00122	0.0025	CcSEcCtD
Cefdinir—Dizziness—Imiquimod—skin cancer	0.00121	0.00248	CcSEcCtD
Cefdinir—Leukopenia—Temozolomide—skin cancer	0.0012	0.00247	CcSEcCtD
Cefdinir—Neutropenia—Docetaxel—skin cancer	0.0012	0.00246	CcSEcCtD
Cefdinir—Thrombocytopenia—Dactinomycin—skin cancer	0.00119	0.00244	CcSEcCtD
Cefdinir—SLC22A5—nipple—skin cancer	0.00118	0.0614	CbGeAlD
Cefdinir—Convulsion—Temozolomide—skin cancer	0.00116	0.00239	CcSEcCtD
Cefdinir—Vomiting—Imiquimod—skin cancer	0.00116	0.00239	CcSEcCtD
Cefdinir—Hypertension—Temozolomide—skin cancer	0.00116	0.00238	CcSEcCtD
Cefdinir—Anorexia—Dactinomycin—skin cancer	0.00116	0.00237	CcSEcCtD
Cefdinir—Rash—Imiquimod—skin cancer	0.00115	0.00237	CcSEcCtD
Cefdinir—Dermatitis—Imiquimod—skin cancer	0.00115	0.00237	CcSEcCtD
Cefdinir—Pneumonia—Docetaxel—skin cancer	0.00115	0.00236	CcSEcCtD
Cefdinir—Headache—Imiquimod—skin cancer	0.00115	0.00235	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.00113	0.00233	CcSEcCtD
Cefdinir—Decreased appetite—Bleomycin—skin cancer	0.00113	0.00232	CcSEcCtD
Cefdinir—Acute coronary syndrome—Docetaxel—skin cancer	0.00113	0.00231	CcSEcCtD
Cefdinir—Renal failure—Docetaxel—skin cancer	0.00112	0.00231	CcSEcCtD
Cefdinir—Myocardial infarction—Docetaxel—skin cancer	0.00112	0.0023	CcSEcCtD
Cefdinir—Dry mouth—Temozolomide—skin cancer	0.00112	0.0023	CcSEcCtD
Cefdinir—Stomatitis—Docetaxel—skin cancer	0.00111	0.00229	CcSEcCtD
Cefdinir—Jaundice—Docetaxel—skin cancer	0.00111	0.00229	CcSEcCtD
Cefdinir—Conjunctivitis—Docetaxel—skin cancer	0.00111	0.00228	CcSEcCtD
Cefdinir—Leukopenia—Fluorouracil—skin cancer	0.00111	0.00228	CcSEcCtD
Cefdinir—Anaphylactic shock—Temozolomide—skin cancer	0.0011	0.00225	CcSEcCtD
Cefdinir—Nausea—Imiquimod—skin cancer	0.00109	0.00223	CcSEcCtD
Cefdinir—Thrombocytopenia—Temozolomide—skin cancer	0.00107	0.0022	CcSEcCtD
Cefdinir—Convulsion—Fluorouracil—skin cancer	0.00107	0.0022	CcSEcCtD
Cefdinir—Agranulocytosis—Docetaxel—skin cancer	0.00107	0.00219	CcSEcCtD
Cefdinir—Chest pain—Fluorouracil—skin cancer	0.00105	0.00216	CcSEcCtD
Cefdinir—Decreased appetite—Dactinomycin—skin cancer	0.00105	0.00216	CcSEcCtD
Cefdinir—Anorexia—Temozolomide—skin cancer	0.00105	0.00215	CcSEcCtD
Cefdinir—Haemoglobin—Docetaxel—skin cancer	0.00103	0.00212	CcSEcCtD
Cefdinir—Body temperature increased—Bleomycin—skin cancer	0.00103	0.00211	CcSEcCtD
Cefdinir—Haemorrhage—Docetaxel—skin cancer	0.00103	0.00211	CcSEcCtD
Cefdinir—Anaphylactic shock—Fluorouracil—skin cancer	0.00101	0.00207	CcSEcCtD
Cefdinir—MPO—lymphoid tissue—skin cancer	0.00101	0.0527	CbGeAlD
Cefdinir—Insomnia—Temozolomide—skin cancer	0.000992	0.00204	CcSEcCtD
Cefdinir—Gastrointestinal pain—Dactinomycin—skin cancer	0.000992	0.00204	CcSEcCtD
Cefdinir—Thrombocytopenia—Fluorouracil—skin cancer	0.000989	0.00203	CcSEcCtD
Cefdinir—Somnolence—Temozolomide—skin cancer	0.000975	0.002	CcSEcCtD
Cefdinir—Erythema multiforme—Docetaxel—skin cancer	0.000971	0.00199	CcSEcCtD
Cefdinir—Dyspepsia—Temozolomide—skin cancer	0.000965	0.00198	CcSEcCtD
Cefdinir—Anorexia—Fluorouracil—skin cancer	0.000963	0.00198	CcSEcCtD
Cefdinir—Abdominal pain—Dactinomycin—skin cancer	0.000959	0.00197	CcSEcCtD
Cefdinir—Body temperature increased—Dactinomycin—skin cancer	0.000959	0.00197	CcSEcCtD
Cefdinir—Hypersensitivity—Bleomycin—skin cancer	0.000958	0.00197	CcSEcCtD
Cefdinir—Decreased appetite—Temozolomide—skin cancer	0.000953	0.00196	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Temozolomide—skin cancer	0.000947	0.00194	CcSEcCtD
Cefdinir—Constipation—Temozolomide—skin cancer	0.000938	0.00193	CcSEcCtD
Cefdinir—Asthenia—Bleomycin—skin cancer	0.000933	0.00192	CcSEcCtD
Cefdinir—Pruritus—Bleomycin—skin cancer	0.00092	0.00189	CcSEcCtD
Cefdinir—Insomnia—Fluorouracil—skin cancer	0.000914	0.00188	CcSEcCtD
Cefdinir—Somnolence—Fluorouracil—skin cancer	0.000898	0.00184	CcSEcCtD
Cefdinir—Gastrointestinal pain—Temozolomide—skin cancer	0.000897	0.00184	CcSEcCtD
Cefdinir—Hypersensitivity—Dactinomycin—skin cancer	0.000893	0.00183	CcSEcCtD
Cefdinir—Dyspepsia—Fluorouracil—skin cancer	0.000889	0.00183	CcSEcCtD
Cefdinir—Decreased appetite—Fluorouracil—skin cancer	0.000878	0.0018	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000872	0.00179	CcSEcCtD
Cefdinir—Asthenia—Dactinomycin—skin cancer	0.00087	0.00179	CcSEcCtD
Cefdinir—Abdominal pain—Temozolomide—skin cancer	0.000867	0.00178	CcSEcCtD
Cefdinir—Body temperature increased—Temozolomide—skin cancer	0.000867	0.00178	CcSEcCtD
Cefdinir—Diarrhoea—Dactinomycin—skin cancer	0.00083	0.0017	CcSEcCtD
Cefdinir—Vomiting—Bleomycin—skin cancer	0.000827	0.0017	CcSEcCtD
Cefdinir—Rash—Bleomycin—skin cancer	0.00082	0.00168	CcSEcCtD
Cefdinir—Dermatitis—Bleomycin—skin cancer	0.000819	0.00168	CcSEcCtD
Cefdinir—MPO—head—skin cancer	0.000813	0.0424	CbGeAlD
Cefdinir—Hypersensitivity—Temozolomide—skin cancer	0.000808	0.00166	CcSEcCtD
Cefdinir—Leukopenia—Docetaxel—skin cancer	0.0008	0.00164	CcSEcCtD
Cefdinir—Body temperature increased—Fluorouracil—skin cancer	0.000799	0.00164	CcSEcCtD
Cefdinir—Asthenia—Temozolomide—skin cancer	0.000787	0.00162	CcSEcCtD
Cefdinir—Loss of consciousness—Docetaxel—skin cancer	0.000785	0.00161	CcSEcCtD
Cefdinir—Pruritus—Temozolomide—skin cancer	0.000776	0.00159	CcSEcCtD
Cefdinir—Convulsion—Docetaxel—skin cancer	0.000774	0.00159	CcSEcCtD
Cefdinir—Nausea—Bleomycin—skin cancer	0.000772	0.00159	CcSEcCtD
Cefdinir—Hypertension—Docetaxel—skin cancer	0.000772	0.00158	CcSEcCtD
Cefdinir—Vomiting—Dactinomycin—skin cancer	0.000771	0.00158	CcSEcCtD
Cefdinir—Rash—Dactinomycin—skin cancer	0.000765	0.00157	CcSEcCtD
Cefdinir—Chest pain—Docetaxel—skin cancer	0.000761	0.00156	CcSEcCtD
Cefdinir—SLC22A5—skin of body—skin cancer	0.000753	0.0393	CbGeAlD
Cefdinir—Diarrhoea—Temozolomide—skin cancer	0.00075	0.00154	CcSEcCtD
Cefdinir—Hypersensitivity—Fluorouracil—skin cancer	0.000744	0.00153	CcSEcCtD
Cefdinir—Dry mouth—Docetaxel—skin cancer	0.000744	0.00153	CcSEcCtD
Cefdinir—Anaphylactic shock—Docetaxel—skin cancer	0.000729	0.0015	CcSEcCtD
Cefdinir—Dizziness—Temozolomide—skin cancer	0.000725	0.00149	CcSEcCtD
Cefdinir—Nausea—Dactinomycin—skin cancer	0.00072	0.00148	CcSEcCtD
Cefdinir—Shock—Docetaxel—skin cancer	0.000718	0.00147	CcSEcCtD
Cefdinir—Pruritus—Fluorouracil—skin cancer	0.000715	0.00147	CcSEcCtD
Cefdinir—Thrombocytopenia—Docetaxel—skin cancer	0.000714	0.00147	CcSEcCtD
Cefdinir—Vomiting—Temozolomide—skin cancer	0.000697	0.00143	CcSEcCtD
Cefdinir—Anorexia—Docetaxel—skin cancer	0.000695	0.00143	CcSEcCtD
Cefdinir—Rash—Temozolomide—skin cancer	0.000691	0.00142	CcSEcCtD
Cefdinir—Diarrhoea—Fluorouracil—skin cancer	0.000691	0.00142	CcSEcCtD
Cefdinir—Dermatitis—Temozolomide—skin cancer	0.000691	0.00142	CcSEcCtD
Cefdinir—Headache—Temozolomide—skin cancer	0.000687	0.00141	CcSEcCtD
Cefdinir—SLC15A2—female reproductive system—skin cancer	0.000676	0.0353	CbGeAlD
Cefdinir—Dizziness—Fluorouracil—skin cancer	0.000668	0.00137	CcSEcCtD
Cefdinir—Insomnia—Docetaxel—skin cancer	0.00066	0.00135	CcSEcCtD
Cefdinir—Nausea—Temozolomide—skin cancer	0.000651	0.00134	CcSEcCtD
Cefdinir—Somnolence—Docetaxel—skin cancer	0.000648	0.00133	CcSEcCtD
Cefdinir—Vomiting—Fluorouracil—skin cancer	0.000642	0.00132	CcSEcCtD
Cefdinir—Dyspepsia—Docetaxel—skin cancer	0.000642	0.00132	CcSEcCtD
Cefdinir—Rash—Fluorouracil—skin cancer	0.000637	0.00131	CcSEcCtD
Cefdinir—Dermatitis—Fluorouracil—skin cancer	0.000637	0.00131	CcSEcCtD
Cefdinir—Decreased appetite—Docetaxel—skin cancer	0.000634	0.0013	CcSEcCtD
Cefdinir—Headache—Fluorouracil—skin cancer	0.000633	0.0013	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Docetaxel—skin cancer	0.00063	0.00129	CcSEcCtD
Cefdinir—Constipation—Docetaxel—skin cancer	0.000624	0.00128	CcSEcCtD
Cefdinir—Nausea—Fluorouracil—skin cancer	0.0006	0.00123	CcSEcCtD
Cefdinir—Gastrointestinal pain—Docetaxel—skin cancer	0.000596	0.00122	CcSEcCtD
Cefdinir—SLC22A5—female reproductive system—skin cancer	0.000588	0.0307	CbGeAlD
Cefdinir—Abdominal pain—Docetaxel—skin cancer	0.000577	0.00118	CcSEcCtD
Cefdinir—Body temperature increased—Docetaxel—skin cancer	0.000577	0.00118	CcSEcCtD
Cefdinir—MPO—lymph node—skin cancer	0.000569	0.0297	CbGeAlD
Cefdinir—SLC15A2—head—skin cancer	0.000565	0.0295	CbGeAlD
Cefdinir—Hypersensitivity—Docetaxel—skin cancer	0.000537	0.0011	CcSEcCtD
Cefdinir—Asthenia—Docetaxel—skin cancer	0.000523	0.00107	CcSEcCtD
Cefdinir—Pruritus—Docetaxel—skin cancer	0.000516	0.00106	CcSEcCtD
Cefdinir—Diarrhoea—Docetaxel—skin cancer	0.000499	0.00102	CcSEcCtD
Cefdinir—Dizziness—Docetaxel—skin cancer	0.000482	0.00099	CcSEcCtD
Cefdinir—Vomiting—Docetaxel—skin cancer	0.000464	0.000952	CcSEcCtD
Cefdinir—Rash—Docetaxel—skin cancer	0.00046	0.000944	CcSEcCtD
Cefdinir—Dermatitis—Docetaxel—skin cancer	0.000459	0.000943	CcSEcCtD
Cefdinir—Headache—Docetaxel—skin cancer	0.000457	0.000938	CcSEcCtD
Cefdinir—Nausea—Docetaxel—skin cancer	0.000433	0.00089	CcSEcCtD
Cefdinir—SLC15A2—lymph node—skin cancer	0.000395	0.0206	CbGeAlD
Cefdinir—SLC22A5—lymph node—skin cancer	0.000344	0.018	CbGeAlD
